Concord Healthcare Reports 8.3% Revenue Decline, Narrowed Net Loss for H1 2025; EPS Improves to RMB (0.24)

Reuters

Aug 28

Concord Healthcare Reports 8.3% Revenue Decline, Narrowed Net Loss for H1 2025; EPS Improves to RMB (0.24)

Concord Healthcare Group Co. Ltd. released its interim financial results for the six months ended June 30, 2025. The company reported a decrease in revenue by 8.3%, from RMB219.0 million in the same period of 2024 to RMB200.9 million in 2025. Despite the overall revenue decline, revenue from hospital operations saw an increase of 11.2%, rising from RMB137.8 million in 2024 to RMB153.2 million in 2025. The group achieved a turnaround in gross profit, reporting RMB0.4 million for the first half of 2025 compared to a gross loss of RMB34.5 million in the same period of the previous year. Net loss slightly decreased by 1.0%, with the figure standing at RMB200.0 million for the first half of 2025, down from RMB202.0 million in 2024. Concord Healthcare Group focuses on the high-end oncology healthcare sector and operates four offline self-operated hospitals. The company continues to manage its operations amidst the financial challenges, showing improvements in certain areas such as hospital revenue and gross profit.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Concord Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 28, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2562105532"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2562105532\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2562105532?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-28 22:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2562105532","market":"fut","top_or_hot":-1,"title":"Concord Healthcare Reports 8.3% Revenue Decline, Narrowed Net Loss for H1 2025; EPS Improves to RMB (0.24)","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Concord Healthcare Reports 8.3% Revenue Decline, Narrowed Net Loss for H1 2025; EPS Improves to RMB (0.24)\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Concord Healthcare Group Co. Ltd. released its interim financial results for the six months ended June 30, 2025. The company reported a decrease in revenue by 8.3%, from RMB219.0 million in the same period of 2024 to RMB200.9 million in 2025. Despite the overall revenue decline, revenue from hospital operations saw an increase of 11.2%, rising from RMB137.8 million in 2024 to RMB153.2 million in 2025. The group achieved a turnaround in gross profit, reporting RMB0.4 million for the first half of 2025 compared to a gross loss of RMB34.5 million in the same period of the previous year. Net loss slightly decreased by 1.0%, with the figure standing at RMB200.0 million for the first half of 2025, down from RMB202.0 million in 2024. Concord Healthcare Group focuses on the high-end oncology healthcare sector and operates four offline self-operated hospitals. The company continues to manage its operations amidst the financial challenges, showing improvements in certain areas such as hospital revenue and gross profit.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Concord Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 28, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Concord Healthcare Reports 8.3% Revenue Decline, Narrowed Net Loss for H1 2025; EPS Improves to RMB (0.24)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConcord Healthcare Reports 8.3% Revenue Decline, Narrowed Net Loss for H1 2025; EPS Improves to RMB (0.24)\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-28 22:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Concord Healthcare Reports 8.3% Revenue Decline, Narrowed Net Loss for H1 2025; EPS Improves to RMB (0.24)\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Concord Healthcare Group Co. Ltd. released its interim financial results for the six months ended June 30, 2025. The company reported a decrease in revenue by 8.3%, from RMB219.0 million in the same period of 2024 to RMB200.9 million in 2025. Despite the overall revenue decline, revenue from hospital operations saw an increase of 11.2%, rising from RMB137.8 million in 2024 to RMB153.2 million in 2025. The group achieved a turnaround in gross profit, reporting RMB0.4 million for the first half of 2025 compared to a gross loss of RMB34.5 million in the same period of the previous year. Net loss slightly decreased by 1.0%, with the figure standing at RMB200.0 million for the first half of 2025, down from RMB202.0 million in 2024. Concord Healthcare Group focuses on the high-end oncology healthcare sector and operates four offline self-operated hospitals. The company continues to manage its operations amidst the financial challenges, showing improvements in certain areas such as hospital revenue and gross profit.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Concord Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 28, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02453","symbol_name":"美中嘉和","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL9Mkq80:1","article_id":"2562105532","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2562105532","pubTimestamp":1756390202,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Concord Healthcare Group Co. Ltd. released its interim financial results for the six months ended June 30, 2025. The company reported a decrease in revenue by 8.3%, from RMB219.0 million in the same period of 2024 to RMB200.9 million in 2025. Despite the overall revenue decline, revenue from hospital operations saw an increase of 11.2%, rising from RMB137.8 million in 2024 to RMB153.2 million in 2025. The group achieved a turnaround in gross profit, reporting RMB0.4 million for the first half of 2025 compared to a gross loss of RMB34.5 million in the same period of the previous year. Net loss slightly decreased by 1.0%, with the figure standing at RMB200.0 million for the first half of 2025, down from RMB202.0 million in 2024. Concord Healthcare Group focuses on the high-end oncology healthcare sector and operates four offline self-operated hospitals. The company continues to manage its operations amidst the financial challenges, showing improvements in certain areas such as hospital r","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"02453":"美中嘉和"},"translate_title":"Concord Healthcare报告2025年上半年收入下降8.3%，净亏损收窄；每股收益改善至人民币(0.24)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02453":0.9},"content_text":"Concord Healthcare Reports 8.3% Revenue Decline, Narrowed Net Loss for H1 2025; EPS Improves to RMB (0.24)\n    \n\n        Concord Healthcare Group Co. Ltd. released its interim financial results for the six months ended June 30, 2025. The company reported a decrease in revenue by 8.3%, from RMB219.0 million in the same period of 2024 to RMB200.9 million in 2025. Despite the overall revenue decline, revenue from hospital operations saw an increase of 11.2%, rising from RMB137.8 million in 2024 to RMB153.2 million in 2025. The group achieved a turnaround in gross profit, reporting RMB0.4 million for the first half of 2025 compared to a gross loss of RMB34.5 million in the same period of the previous year. Net loss slightly decreased by 1.0%, with the figure standing at RMB200.0 million for the first half of 2025, down from RMB202.0 million in 2024. Concord Healthcare Group focuses on the high-end oncology healthcare sector and operates four offline self-operated hospitals. The company continues to manage its operations amidst the financial challenges, showing improvements in certain areas such as hospital revenue and gross profit.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Concord Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 28, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}